Lessee, Operating Lease, Liability, to be Paid, Year Three in USD of Intra-Cellular Therapies, Inc. from Q1 2019 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Summary
Intra-Cellular Therapies, Inc. quarterly Lessee, Operating Lease, Liability, to be Paid, Year Three history and change rate from Q1 2019 to Q4 2024.
  • Intra-Cellular Therapies, Inc. Lessee, Operating Lease, Liability, to be Paid, Year Three for the quarter ending 31 Dec 2024 was $4.57M, a 15.1% increase year-over-year.
Lessee, Operating Lease, Liability, to be Paid, Year Three, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, Year Three, YoY Quarterly Change (%)

Intra-Cellular Therapies, Inc. Quarterly Lessee, Operating Lease, Liability, to be Paid, Year Three (USD)

Period Value YoY Chg Change % Date Report Filed
Q4 2024 $4.57M +$599K +15.1% 31 Dec 2024 10-K 21 Feb 2025
Q3 2024 $4.57M +$599K +15.1% 30 Sep 2024 10-Q 30 Oct 2024
Q2 2024 $4.57M +$599K +15.1% 30 Jun 2024 10-Q 07 Aug 2024
Q1 2024 $4.02M +$48K +1.21% 31 Mar 2024 10-Q 07 May 2024
Q4 2023 $3.97M 31 Dec 2023 10-K 22 Feb 2024
Q3 2023 $3.97M 30 Sep 2023 10-Q 02 Nov 2023
Q2 2023 $3.97M 30 Jun 2023 10-Q 03 Aug 2023
Q1 2023 $3.97M 31 Mar 2023 10-Q 04 May 2023
Q4 2019 $3.49M 31 Dec 2019 10-K 02 Mar 2020
Q3 2019 $3.45M 30 Sep 2019 10-Q 05 Nov 2019
Q2 2019 $3.45M 30 Jun 2019 10-Q 07 Aug 2019
Q1 2019 $3.45M 31 Mar 2019 10-Q 08 May 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.